ロード中...
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
The 2014–2015 Ebola epidemic affected several African countries, claiming more than 11,000 lives and leaving thousands with ongoing sequelae. Safe and effective vaccines could prevent or limit future outbreaks. The recombinant vesicular stomatitis virus–vectored Zaire Ebola (rVSV-ZEBOV) vaccine has...
保存先:
| 出版年: | Sci Transl Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6379059/ https://ncbi.nlm.nih.gov/pubmed/28404856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaj1701 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|